论文信息 - FDA Approval Summary: Atezolizumab Plus Paclitaxel Protein-bound for the Treatment of Patients with Advanced or Metastatic TNBC Whose Tumors Express PD-L1 - 字舞流文

FDA Approval Summary: Atezolizumab Plus Paclitaxel Protein-bound for the Treatment of Patients with Advanced or Metastatic TNBC Whose Tumors Express PD-L1

Jiang Liu | Reena Philip | K. Goldberg | R. Pazdur | B. King-Kallimanis | L. Amiri-Kordestani | G. Blumenthal | R. Sridhara | Shenghui Tang | M. Theoret | A. Ibrahim | J. Beaver | P. Kluetz | E. Bloomquist | P. Song | Y. Gong | Soma Ghosh | P. Narayan | Sherry Hou | Jennifer J. Gao | Shyam Kalavar | W. Fu | Sakar Wahby | Yuan Xu | S. Wahby